Skip to main content
. Author manuscript; available in PMC: 2011 May 15.
Published in final edited form as: Cancer Immunol Immunother. 2011 Feb 22;60(5):731–738. doi: 10.1007/s00262-011-0971-0

Fig. 2. Representative pictures of primary and metastatic tumors after treatment.

Fig. 2

Representative pictures of an NXS2 primary tumor from a DMSO-treated and RV-treated mouse (a), and of organs where metastatic tumors were observed after microscopic examination (b), after treatment completion.